| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005583862 |
| P356 | DOI | 10.1208/S12248-010-9240-Y |
| P932 | PMC publication ID | 3032094 |
| P698 | PubMed publication ID | 21057907 |
| P5875 | ResearchGate publication ID | 47701750 |
| P50 | author | Raimar Löbenberg | Q41842131 |
| P2093 | author name string | Wilson H Roa | |
| Shirzad Azarmi | |||
| Muhammad Khan Sarfraz | |||
| M H D Kamal Al-Hallak | |||
| M H Gilzad Kohan | |||
| P2860 | cites work | The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes | Q28184994 |
| Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles | Q33244142 | ||
| Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells. | Q33250607 | ||
| Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. | Q33879575 | ||
| Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
| Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 | ||
| Different fates of phagocytosed particles after delivery into macrophage lysosomes. | Q36382371 | ||
| Cytochalasin B reversibly inhibits phagocytosis: functional, metabolic, and ultrastructural effects in human blood leukocytes and rabbit alveolar macrophages | Q36991610 | ||
| Isothermal titration calorimetry. | Q37070673 | ||
| Targeted delivery of nanoparticles for the treatment of lung diseases. | Q37097511 | ||
| Physical characterization and macrophage cell uptake of mannan-coated nanoparticles | Q38352053 | ||
| Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats | Q38548001 | ||
| Phagocytosis and degradation of human serum albumin microspheres and nanoparticles in human macrophages | Q38569781 | ||
| Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy? | Q39706222 | ||
| Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. | Q40158060 | ||
| Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro | Q40864447 | ||
| Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting | Q40947914 | ||
| Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments | Q41182472 | ||
| The influence of some metabolic inhibitors on phagocytic activity of mouse macrophages in vitro | Q41465787 | ||
| Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. | Q41621752 | ||
| Pulmonary toxicity of polysorbate-80-coated inhalable nanoparticles; in vitro and in vivo evaluation | Q41849715 | ||
| Inhibition of HIV in vitro by antiviral drug-targeting using nanoparticles | Q42279953 | ||
| Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery | Q46799341 | ||
| Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. | Q48784173 | ||
| Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice | Q68514006 | ||
| Flow cytometric quantitative evaluation of phagocytosis by human mononuclear and polymorphonuclear cells using fluorescent nanoparticles | Q69727063 | ||
| Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis | Q70439654 | ||
| Overview of flow cytometry and fluorescent probes for cytometry | Q71687393 | ||
| Macrophage targeting of azidothymidine: a promising strategy for AIDS therapy | Q71871769 | ||
| Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System | Q71943642 | ||
| Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles | Q73825954 | ||
| Mannose-targeted systems for the delivery of therapeutics | Q81406406 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| macrophage | Q184204 | ||
| phagocytosis | Q184726 | ||
| P304 | page(s) | 20-29 | |
| P577 | publication date | 2010-11-06 | |
| P1433 | published in | The AAPS Journal | Q10695361 |
| P1476 | title | Microcalorimetric method to assess phagocytosis: macrophage-nanoparticle interactions | |
| P478 | volume | 13 |
| Q59237431 | Distribution of effervescent inhalable nanoparticles after pulmonary delivery: anin vivostudy |
| Q53586562 | Phagocytosis and immune response studies of Macrophage-Nanodiamond Interactions in vitro and in vivo. |
| Q38028967 | Pulmonary delivery of inhalable nanoparticles: dry powder inhalers |
| Q38090525 | Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery |
Search more.